Dysport is an FDA-approved treatment used to reduce the appearance of fine lines and wrinkles by relaxing facial muscles. Similar to BOTOX® Cosmetic, Dysport is injected directly into the site of wrinkles to prevent the underlying muscles from contracting. The active ingredient in Dysport is botulinum toxin type A. The inactive ingredient is human albumin and lactose. Dysport may contain cow’s milk protein.
Dysport was developed in Europe during the early 1990s, and has been used there successfully for several years. In April 2009, Dysport was approved by the FDA for use in the US, and is expected to rival Botox, the most popular cosmetic procedure, with its convenience and long-lasting results.
Park Avenue Medical Spa is located in Armonk, NY and we are grateful to serve the wonderful communities of Westchester, Yonkers, Stamford, CT, and the surrounding areas. Dr. Tchelebi-Moscatello and our team are experts in medical aesthetics and are pleased to offer a wide range of cosmetic and wellness treatments. Schedule your consultation today by calling our office or filling out an online contact form. We look forward to helping you take the first step toward overall wellness and your aesthetic goals.
The ASPIRE Galderma Rewards allows you to earn points towards your next Dysport treatment.
Dr. Tchelebi-Moscatello is a board-certified radiation oncologist and medical aesthetics specialist with a focus on cosmetic services. She studied medical aesthetics in Paris, France, and continues to stay updated with the latest aesthetic techniques under leaders in the field to provide patients with beautiful, natural-looking results. Along with being a member of the Academy of Cosmetic Physicians, the American Academy of Medical Aesthetics, The American Academy of Cosmetic Surgery, and the American Academy of Mesotherapy, Dr. Tchelebi-Moscatello is also a member of the International Society of Hair Restoration Surgery.